Pharmaceutical Industry Articles & Reports - Page 14

Read this guide on evaluating digital quality systems (eQMS) for CDMOs. Learn about contract manufacturing software selection, GMP compliance, and integration.

Analyze leading GxP compliance software, eQMS, and document management platforms for life sciences. Learn how systems meet 21 CFR Part 11 and ALCOA+ rules.

Compare ELN, LIMS, and SDMS for pharmaceutical labs. This 2026 guide explains architectural differences, features, compliance, and specific R&D use cases.

Learn how pharma companies build regulatory-grade real-world evidence (RWE) platforms using real-world data for FDA and EMA drug development submissions.

An overview of molecular pathology software, examining LIMS for NGS workflows, multi-omics data integration, and AI analysis tools in precision medicine.

Examine the integration of AI in pharmaceutical CMC submissions and process analytics. Review QbD frameworks, regulatory guidelines, and manufacturing outcomes.

Review NIS2 Directive requirements for the pharma industry. This 2026 cybersecurity compliance checklist covers IT/OT, supply chain, and incident reporting.

Analyze the impact of 2026 U.S. pharma tariffs on global drug supply chains, manufacturing onshoring investments, and digital IT strategy for compliance.

A comprehensive comparison of RTSM software and IRT platforms for clinical trials. Analyze randomization features, trial supply management, and vendor options.

Examine how the EU Digital Omnibus impacts pharma AI and medical device compliance. Review AI Act timeline extensions, MDR integration, and GDPR data updates.

Explore a 90-day diagnostic framework for assessing AI readiness in pharma. Learn how to evaluate data governance, regulatory compliance, and integration.

Analyze AI governance in pharmacovigilance signal detection. Review CIOMS XIV and TransCelerate frameworks for risk-based oversight in drug safety monitoring.

Explore the agentic AI decision framework for the pharmaceutical industry. Learn how to assess build, buy, and partner models for clinical and R&D workflows.

Examine how agentic AI and systems like Microsoft Copilot support corporate PowerPoint workflows in 2026 by automating presentation creation and editing.

Guide to deploying AI in pharmacovigilance under the CIOMS XIV framework. Review core principles for risk-based oversight, model validation, and governance.

An in-depth comparison of leading pharma MES software: PAS-X, Tulip, MasterControl, and PharmaSuite. Analyze EBR, 21 CFR 11 compliance, and Pharma 4.0.

Explore Ironclad AI capabilities in contract lifecycle management. This deep dive explains agentic architecture, AI Assist, and generative legal tech tools.

Analyze the scientific research capabilities of GPT-5.4 and Claude 4.6. Review how million-token context windows and autonomous tool-use aid data analysis.

Explore the architecture and market dynamics of pharmacy management SaaS platforms. Learn about cloud hosting, EHR interoperability, and 2026 growth trends.

Examine the FDA and EMA Good AI Practice guidelines. This comprehensive implementation guide details the 10 regulatory principles for AI in drug development.

Analyze GLP-1 drug manufacturing dynamics, detailing global capacity expansions, CDMO production strategies, and peptide synthesis tech transfer processes.

Examine frameworks for calculating AI ROI in the pharmaceutical sector. Analyze quantitative metrics and payback periods for PV, regulatory, and manufacturing.

An analysis of EU AI Act high-risk compliance for pharmaceutical and medical device AI. Covers MDR/IVDR integration, data governance, and 2026 deadlines.

Examine HCP Master Data Management in pharma. Review data validation rules, identity verification, and Sunshine Act compliance for aggregate spend reporting.